Shares of NASDAQ:PETS opened at $16.23 on Wednesday. The stock has a 50-day simple moving average of $16.42. Petmed Express has a 12-month low of $15.00 and a 12-month high of $41.45. The firm has a market cap of $329.24 million, a price-to-earnings ratio of 8.85 and a beta of 0.52.
Petmed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, May 6th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.14). Petmed Express had a return on equity of 28.96% and a net margin of 13.32%. The business had revenue of $64.57 million during the quarter, compared to analyst estimates of $69.06 million. During the same period in the previous year, the business posted $0.50 earnings per share. The firm’s quarterly revenue was down 4.1% on a year-over-year basis.
A number of large investors have recently modified their holdings of the business. American Century Companies Inc. purchased a new position in shares of Petmed Express in the 4th quarter worth about $6,088,000. Deutsche Bank AG raised its holdings in shares of Petmed Express by 166.1% in the 4th quarter. Deutsche Bank AG now owns 329,962 shares of the company’s stock worth $7,673,000 after purchasing an additional 205,960 shares during the period. LSV Asset Management raised its holdings in shares of Petmed Express by 35.0% in the 1st quarter. LSV Asset Management now owns 762,337 shares of the company’s stock worth $17,366,000 after purchasing an additional 197,550 shares during the period. Rothschild Investment Corp IL purchased a new position in shares of Petmed Express in the 1st quarter worth about $2,668,000. Finally, Amundi Pioneer Asset Management Inc. purchased a new position in shares of Petmed Express in the 1st quarter worth about $2,475,000. 99.75% of the stock is currently owned by hedge funds and other institutional investors.
Petmed Express Company Profile
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Featured Article: What is a recession?
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.